CSE/DMED (CSE/DMED)

Canadian Securities Exchange: CSE/DMED · CAD

CA$0.03

+0.00 (0.0%)· Recorded snapshot

Market cap	3.9M
Net income (ttm)	-1.9M
EPS (ttm)	-CA$0.02
Shares out	131.6M
Volume	95,927
Beta	-1.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.9M
EPS (ttm): -CA$0.02
Market cap: 3.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/DMED indicators

Market & fundamental data

Available fields

123

Groups with data

Currency

CAD

Showing 123 of 123 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2027-01-29
Enterprise value	CAD 3.7M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA25245D1033
Last earnings date	2026-01-30
Last refreshed	2026-10-29
Market cap	CAD 3.9M
Next earnings date	2027-01-29
Price	CAD 0.03
Price currency	CAD
Sector	Healthcare
SIC code	7372
Stock price date	2026-10-29
Symbol	cse/DMED
Website	https://www.diagnamed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-54.82%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-347.95%
ROCE	967.85%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -1.7M
EPS	CAD -0.02
Financing cash flow	CAD 615,023
Net cash flow	CAD 32,295
Net income	CAD -1.9M
Operating cash flow minus SBC	CAD -1.2M
Operating income	CAD -1.7M
Stock-based compensation	CAD 579,890

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.00
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD 293,759
Net cash / market cap	7.44%
Net cash growth	12.35%
Piotroski F-Score	1
Shareholders' equity	CAD -178,004
Tangible book value	CAD -178,004
Tangible book value per share	CAD -0.00
Total assets	CAD 330,816
Total cash	CAD 293,759
Total debt	CAD 0
Total liabilities	CAD 508,820
WACC	-1.54%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 330,816
Current liabilities	CAD 508,820
Current ratio	0.65
Net working capital	CAD -471,763
Quick ratio	0.6
Working capital	CAD -178,004

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-30.37%
Shareholder yield	-30.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.06
1D price change	0%
1M price change	-33.33%
1M total return	-33.33%
1Y price change	-57.14%
1Y return CAGR	-57.17%
1Y total return	-57.14%
20-day SMA	CAD 0.04
200-day SMA	CAD 0.07
3M price change	-40%
3M total return	-40%
3Y price change	-25%
3Y return CAGR	-9.14%
3Y total return	-25%
50-day SMA	CAD 0.04
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.25
52-week high date	2026-03-12
52-week low	CAD 0.03
52-week low date	2026-10-29
6M price change	-57.14%
6M total return	-57.14%
All-time high	CAD 0.25
All-time high date	2026-03-12
All-time low	CAD 0.01
All-time low date	2024-09-17
Average true range (ATR)	CAD 0.00
Average volume	200.9K
Beta (1Y)	1.46
Beta (2Y)	2.3
Beta (5Y)	-1.05
Change from 52-week high	-88%
Change from 52-week low	0%
Change from all-time high	-88%
Change from all-time low	500%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 2,878
High price	CAD 0.03
Low price	CAD 0.03
Monthly RSI	42.63
Open price	CAD 0.03
Previous close	CAD 0.03
Price vs 150-day SMA	-46.43%
Price vs 20-day SMA	-14.29%
Price vs 200-day SMA	-54.55%
Price vs 50-day SMA	-31.97%
Relative volume	0.48
RSI	41.18
Sharpe ratio	0.13
Sharpe ratio (3Y)	0.91
Sortino ratio	0.27
Sortino ratio (3Y)	1.69
Volume	95.9K
Weekly RSI	35.86
YTD price change	-53.85%
YTD total return	-53.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	124M
Shares change (QoQ)	0%
Shares change (YoY)	30.37%
Shares held by insiders	5.62%
Shares outstanding	131.6M

Deeper analysis on CSE/DMED

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/DMED report

Is a complete CSE/DMED research report available?

No complete published report is available for cse/DMED (CSE/DMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/DMED (CSE/DMED)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/DMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/DMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/DMED

Frequently asked questions